Skip to main content
Erschienen in: International Journal of Hematology 3/2012

01.03.2012 | Original Article

Impaired cell adhesion, apoptosis, and signaling in WASP gene-disrupted Nalm-6 pre-B cells and recovery of cell adhesion using a transducible form of WASp

verfasst von: Rikiya Sato, Susumu Iiizumi, Eun-Sung Kim, Fumiko Honda, Sang-Kyou Lee, Noritaka Adachi, Hideki Koyama, Shuki Mizutani, Tomohiro Morio

Erschienen in: International Journal of Hematology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Wiskott–Aldrich syndrome (WAS) is an X-linked immunodeficiency disease affecting cell morphology and signal transduction in hematopoietic cells. The function of Wiskott–Aldrich syndrome protein (WASp) and its partners in protein interaction have been studied intensively in mice; however, detailed biochemical characterization of its signal transduction and assessment of its functional consequence in human WASp-deficient lymphocytes remain difficult. In this study, we generated Nalm-6 cells in which the WAS protein gene (WASP) was disrupted by homologous recombination-based gene targeting and a cell-permeable form of recombinant WASp for functional study. The WASP−/− cells showed impaired adhesive capacity and polarization to plate-bound anti-CD47 mAb, anti-CD9 mAb, or to fibronectin. The defective morphological changes were accompanied by impaired intracellular signaling. In addition, the WASp-deficient cells displayed augmented apoptosis induced by CD24 cross-linking. A recombinant fusion protein composed of Hph-1 cell-permeable peptide and WASp prepared in Escherichia coli. Hph-1-WASp was efficiently transduced and expressed in WASP−/− Nalm-6 cells in a dose-dependent manner. The wild-type WASp, but not the mutant restored adhesion capacity, spreading morphology, and cytoskeletal reorganization. Additionally, the recombinant protein was successfully transduced into normal lymphocytes. These findings suggest that gene-disrupted model cell lines and cell-permeable recombinant proteins may serve as important tools for the detailed analysis of intracellular molecules involved in PID.
Literatur
1.
Zurück zum Zitat Wiskott A. Familiärer, angeborener Morbus Werlhofii? Monatsschr Kinderheilkd.1937;68:212–16. Wiskott A. Familiärer, angeborener Morbus Werlhofii? Monatsschr Kinderheilkd.1937;68:212–16.
2.
Zurück zum Zitat Aldrich RA, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 1954;13:133–9.PubMed Aldrich RA, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 1954;13:133–9.PubMed
3.
Zurück zum Zitat Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott–Aldrich syndrome. Cell. 1994;78:635–44.PubMedCrossRef Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott–Aldrich syndrome. Cell. 1994;78:635–44.PubMedCrossRef
4.
Zurück zum Zitat Imai K, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456–64.PubMedCrossRef Imai K, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456–64.PubMedCrossRef
5.
Zurück zum Zitat Jin Y, et al. Mutations of the Wiskott–Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104:4010–9.PubMedCrossRef Jin Y, et al. Mutations of the Wiskott–Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104:4010–9.PubMedCrossRef
6.
Zurück zum Zitat Ochs HD, Thrasher AJ. The Wiskott–Aldrich syndrome. J Allergy Clin immunol. 2006;117:725–38 (quiz 739). Ochs HD, Thrasher AJ. The Wiskott–Aldrich syndrome. J Allergy Clin immunol. 2006;117:725–38 (quiz 739).
7.
Zurück zum Zitat Orange JS, Stone KD, Turvey SE, Krzewski K. The Wiskott–Aldrich syndrome. Cell Mol Life Sci. 2004;61:2361–85.PubMedCrossRef Orange JS, Stone KD, Turvey SE, Krzewski K. The Wiskott–Aldrich syndrome. Cell Mol Life Sci. 2004;61:2361–85.PubMedCrossRef
8.
Zurück zum Zitat Ramesh N, Anton IM, Martinez-Quiles N, Geha RS. Waltzing with WASP. Trends Cell Biol. 1999;9:15–9.PubMedCrossRef Ramesh N, Anton IM, Martinez-Quiles N, Geha RS. Waltzing with WASP. Trends Cell Biol. 1999;9:15–9.PubMedCrossRef
9.
Zurück zum Zitat Takenawa T, Suetsugu S. The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Natl Rev Mol Cell Biol. 2007;8:37–48.CrossRef Takenawa T, Suetsugu S. The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Natl Rev Mol Cell Biol. 2007;8:37–48.CrossRef
10.
Zurück zum Zitat Anton IM, et al. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity. 2002;16:193–204.PubMedCrossRef Anton IM, et al. WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. Immunity. 2002;16:193–204.PubMedCrossRef
11.
Zurück zum Zitat de la Fuente MA, et al. WIP is a chaperone for Wiskott–Aldrich syndrome protein (WASP). Proc Natl Acad Sci USA. 2007;104:926–31.PubMedCrossRef de la Fuente MA, et al. WIP is a chaperone for Wiskott–Aldrich syndrome protein (WASP). Proc Natl Acad Sci USA. 2007;104:926–31.PubMedCrossRef
12.
Zurück zum Zitat Baba Y, et al. Involvement of Wiskott–Aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. Blood. 1999;93:2003–12.PubMed Baba Y, et al. Involvement of Wiskott–Aldrich syndrome protein in B-cell cytoplasmic tyrosine kinase pathway. Blood. 1999;93:2003–12.PubMed
13.
Zurück zum Zitat Banin S, Truong O, Katz DR, Waterfield MD, Brickell PM, Gout I. Wiskott–Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr Biol. 1996;6:981–8.PubMedCrossRef Banin S, Truong O, Katz DR, Waterfield MD, Brickell PM, Gout I. Wiskott–Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr Biol. 1996;6:981–8.PubMedCrossRef
14.
Zurück zum Zitat McGavin MK, Badour K, Hardy LA, Kubiseski TJ, Zhang J, Siminovitch KA. The intersectin 2 adaptor links Wiskott Aldrich syndrome protein (WASp)-mediated actin polymerization to T cell antigen receptor endocytosis. J Exp Med. 2001;194:1777–87.PubMedCrossRef McGavin MK, Badour K, Hardy LA, Kubiseski TJ, Zhang J, Siminovitch KA. The intersectin 2 adaptor links Wiskott Aldrich syndrome protein (WASp)-mediated actin polymerization to T cell antigen receptor endocytosis. J Exp Med. 2001;194:1777–87.PubMedCrossRef
15.
Zurück zum Zitat Yarar D, D’Alessio JA, Jeng RL, Welch MD. Motility determinants in WASP family proteins. Mol Biol Cell. 2002;13:4045–59.PubMedCrossRef Yarar D, D’Alessio JA, Jeng RL, Welch MD. Motility determinants in WASP family proteins. Mol Biol Cell. 2002;13:4045–59.PubMedCrossRef
16.
Zurück zum Zitat Aspenstrom P, Lindberg U, Hall A. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott–Aldrich syndrome. Curr Biol. 1996;6:70–5.PubMedCrossRef Aspenstrom P, Lindberg U, Hall A. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott–Aldrich syndrome. Curr Biol. 1996;6:70–5.PubMedCrossRef
17.
Zurück zum Zitat Tian L, Nelson DL, Stewart DM. Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules. J Biol Chem. 2000;275:7854–61.PubMedCrossRef Tian L, Nelson DL, Stewart DM. Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules. J Biol Chem. 2000;275:7854–61.PubMedCrossRef
18.
Zurück zum Zitat Gerwin N, Friedrich C, Perez-Atayde A, Rosen FS, Gutierrez-Ramos JC. Multiple antigens are altered on T and B lymphocytes from peripheral blood and spleen of patients with Wiskott–Aldrich syndrome. Clin Exp Immunol. 1996;106:208–17.PubMedCrossRef Gerwin N, Friedrich C, Perez-Atayde A, Rosen FS, Gutierrez-Ramos JC. Multiple antigens are altered on T and B lymphocytes from peripheral blood and spleen of patients with Wiskott–Aldrich syndrome. Clin Exp Immunol. 1996;106:208–17.PubMedCrossRef
19.
Zurück zum Zitat Westerberg L, Larsson M, Hardy SJ, Fernandez C, Thrasher AJ, Severinson E. Wiskott–Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 2005;105:1144–52.PubMedCrossRef Westerberg L, Larsson M, Hardy SJ, Fernandez C, Thrasher AJ, Severinson E. Wiskott–Aldrich syndrome protein deficiency leads to reduced B-cell adhesion, migration, and homing, and a delayed humoral immune response. Blood. 2005;105:1144–52.PubMedCrossRef
20.
Zurück zum Zitat Abdul-Manan N, et al. Structure of Cdc42 in complex with the GTPase-binding domain of the ‘Wiskott–Aldrich syndrome’ protein. Nature. 1999;399:379–83.PubMedCrossRef Abdul-Manan N, et al. Structure of Cdc42 in complex with the GTPase-binding domain of the ‘Wiskott–Aldrich syndrome’ protein. Nature. 1999;399:379–83.PubMedCrossRef
21.
Zurück zum Zitat Facchetti F, et al. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott–Aldrich syndrome. J Pathol. 1998;185:99–107.PubMedCrossRef Facchetti F, et al. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott–Aldrich syndrome. J Pathol. 1998;185:99–107.PubMedCrossRef
22.
Zurück zum Zitat Morio T, et al. The increase of non-MHC-restricted cytotoxic cells (gamma/delta-TCR-bearing T cells or NK cells) and the abnormal differentiation of B cells in Wiskott–Aldrich syndrome. Clin Immunol Immunopathol. 1989;52:279–90. Morio T, et al. The increase of non-MHC-restricted cytotoxic cells (gamma/delta-TCR-bearing T cells or NK cells) and the abnormal differentiation of B cells in Wiskott–Aldrich syndrome. Clin Immunol Immunopathol. 1989;52:279–90.
23.
Zurück zum Zitat Park JY, Kob M, Prodeus AP, Rosen FS, Shcherbina A, Remold-O’Donnell E. Early deficit of lymphocytes in Wiskott–Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol. 2004;136:104–10.PubMedCrossRef Park JY, Kob M, Prodeus AP, Rosen FS, Shcherbina A, Remold-O’Donnell E. Early deficit of lymphocytes in Wiskott–Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol. 2004;136:104–10.PubMedCrossRef
24.
Zurück zum Zitat Snapper SB, et al. Wiskott–Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 1998;9:81–91.PubMedCrossRef Snapper SB, et al. Wiskott–Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 1998;9:81–91.PubMedCrossRef
25.
Zurück zum Zitat Wada T, Jagadeesh GJ, Nelson DL, Candotti F. Retrovirus-mediated WASP gene transfer corrects Wiskott–Aldrich syndrome T-cell dysfunction. Hum Gene Ther. 2002;13:1039–46. Wada T, Jagadeesh GJ, Nelson DL, Candotti F. Retrovirus-mediated WASP gene transfer corrects Wiskott–Aldrich syndrome T-cell dysfunction. Hum Gene Ther. 2002;13:1039–46.
26.
Zurück zum Zitat Westerberg L, Greicius G, Snapper SB, Aspenstrom P, Severinson E. Cdc42, Rac1, and the Wiskott–Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes. Blood. 2001;98:1086–94.PubMedCrossRef Westerberg L, Greicius G, Snapper SB, Aspenstrom P, Severinson E. Cdc42, Rac1, and the Wiskott–Aldrich syndrome protein are involved in the cytoskeletal regulation of B lymphocytes. Blood. 2001;98:1086–94.PubMedCrossRef
27.
Zurück zum Zitat Adachi N, et al. The human pre-B cell line Nalm-6 is highly proficient in gene targeting by homologous recombination. DNA Cell Biol. 2006;25:19–24.PubMedCrossRef Adachi N, et al. The human pre-B cell line Nalm-6 is highly proficient in gene targeting by homologous recombination. DNA Cell Biol. 2006;25:19–24.PubMedCrossRef
28.
Zurück zum Zitat Iiizumi S, et al. Simple one-week method to construct gene-targeting vectors: application to production of human knockout cell lines. Biotechniques. 2006;41:311–6.PubMedCrossRef Iiizumi S, et al. Simple one-week method to construct gene-targeting vectors: application to production of human knockout cell lines. Biotechniques. 2006;41:311–6.PubMedCrossRef
29.
Zurück zum Zitat Choi JM, et al. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat Med. 2006;12:574–9.PubMedCrossRef Choi JM, et al. Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammation. Nat Med. 2006;12:574–9.PubMedCrossRef
30.
Zurück zum Zitat Mateo V, et al. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood. 2002;100:2882–90.PubMedCrossRef Mateo V, et al. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization. Blood. 2002;100:2882–90.PubMedCrossRef
31.
Zurück zum Zitat Motegi S, et al. Role of the CD47-SHPS-1 system in regulation of cell migration. EMBO J. 2003;22:2634–44.PubMedCrossRef Motegi S, et al. Role of the CD47-SHPS-1 system in regulation of cell migration. EMBO J. 2003;22:2634–44.PubMedCrossRef
32.
Zurück zum Zitat Ellerman DA, et al. Direct binding of the ligand PSG17 to CD9 requires a CD9 site essential for sperm–egg fusion. Mol Biol Cell. 2003;14:5098–103.PubMedCrossRef Ellerman DA, et al. Direct binding of the ligand PSG17 to CD9 requires a CD9 site essential for sperm–egg fusion. Mol Biol Cell. 2003;14:5098–103.PubMedCrossRef
33.
Zurück zum Zitat Schurman SH, Candotti F. Autoimmunity in Wiskott–Aldrich syndrome. Curr Opin Rheumatol. 2003;15:446–53. Schurman SH, Candotti F. Autoimmunity in Wiskott–Aldrich syndrome. Curr Opin Rheumatol. 2003;15:446–53.
34.
Zurück zum Zitat Suzuki T, Kiyokawa N, Taguchi T, Sekino T, Katagiri YU, Fujimoto J. CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system. J Immunol. 2001;166:5567–77.PubMed Suzuki T, Kiyokawa N, Taguchi T, Sekino T, Katagiri YU, Fujimoto J. CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system. J Immunol. 2001;166:5567–77.PubMed
35.
Zurück zum Zitat Taguchi T, et al. Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells. J Immunol. 2003;170:252–60.PubMed Taguchi T, et al. Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells. J Immunol. 2003;170:252–60.PubMed
36.
Zurück zum Zitat Taguchi T, et al. Deficiency of BLNK hampers PLC-gamma2 phosphorylation and Ca2+ influx induced by the pre-B-cell receptor in human pre-B cells. Immunology. 2004;112:575–82.PubMedCrossRef Taguchi T, et al. Deficiency of BLNK hampers PLC-gamma2 phosphorylation and Ca2+ influx induced by the pre-B-cell receptor in human pre-B cells. Immunology. 2004;112:575–82.PubMedCrossRef
37.
Zurück zum Zitat Rengan R, et al. Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood. 2000;95:1283–92.PubMed Rengan R, et al. Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood. 2000;95:1283–92.PubMed
38.
Zurück zum Zitat Matozaki T, et al. Functions and molecular mechanisms of the CD47-SIRPα signaling pathway. Trends Cell Biol. 2009;19:72–80.PubMedCrossRef Matozaki T, et al. Functions and molecular mechanisms of the CD47-SIRPα signaling pathway. Trends Cell Biol. 2009;19:72–80.PubMedCrossRef
39.
Zurück zum Zitat Imai K, et al. The pleckstrin homology domain of the Wiskott–Aldrich syndrome protein is involved in the organization of actin cytoskeleton. Clin Immunol. 1999;92:128–37.PubMedCrossRef Imai K, et al. The pleckstrin homology domain of the Wiskott–Aldrich syndrome protein is involved in the organization of actin cytoskeleton. Clin Immunol. 1999;92:128–37.PubMedCrossRef
40.
Zurück zum Zitat Cory GO, Garg R, Cramer R, Ridley AJ. Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation. Wiskott–Aldrich syndrome protein. J Biol Chem. 2002;277:45115–21.PubMedCrossRef Cory GO, Garg R, Cramer R, Ridley AJ. Phosphorylation of tyrosine 291 enhances the ability of WASp to stimulate actin polymerization and filopodium formation. Wiskott–Aldrich syndrome protein. J Biol Chem. 2002;277:45115–21.PubMedCrossRef
41.
Zurück zum Zitat Myers SA, Leeper LR, Chung CY. WASP-interacting protein is important for actin filament elongation and prompt pseudopod formation in response to a dynamic chemoattractant gradient. Mol Biol Cell. 2006;17:4564–75.PubMedCrossRef Myers SA, Leeper LR, Chung CY. WASP-interacting protein is important for actin filament elongation and prompt pseudopod formation in response to a dynamic chemoattractant gradient. Mol Biol Cell. 2006;17:4564–75.PubMedCrossRef
42.
Zurück zum Zitat Westerberg LS, et al. Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes. J Exp Med. 2010;207:1145–52.PubMedCrossRef Westerberg LS, et al. Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes. J Exp Med. 2010;207:1145–52.PubMedCrossRef
43.
Zurück zum Zitat Humblet-Baron S, et al. Wiskott–Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest. 2007;117:407–18.PubMedCrossRef Humblet-Baron S, et al. Wiskott–Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest. 2007;117:407–18.PubMedCrossRef
44.
Zurück zum Zitat Morio T, et al. Ku in the cytoplasm associates with CD40 in human B cells and translocates into the nucleus following incubation with IL-4 and anti-CD40 mAb. Immunity. 1999;11:339–48.PubMedCrossRef Morio T, et al. Ku in the cytoplasm associates with CD40 in human B cells and translocates into the nucleus following incubation with IL-4 and anti-CD40 mAb. Immunity. 1999;11:339–48.PubMedCrossRef
45.
Zurück zum Zitat Morio T, Nagasawa M, Nonoyama S, Okawa H, Yata J. Phenotypic profile and functions of T cell receptor-gamma delta-bearing cells from patients with primary immunodeficiency syndrome. J Immunol. 1990;144:1270–5.PubMed Morio T, Nagasawa M, Nonoyama S, Okawa H, Yata J. Phenotypic profile and functions of T cell receptor-gamma delta-bearing cells from patients with primary immunodeficiency syndrome. J Immunol. 1990;144:1270–5.PubMed
Metadaten
Titel
Impaired cell adhesion, apoptosis, and signaling in WASP gene-disrupted Nalm-6 pre-B cells and recovery of cell adhesion using a transducible form of WASp
verfasst von
Rikiya Sato
Susumu Iiizumi
Eun-Sung Kim
Fumiko Honda
Sang-Kyou Lee
Noritaka Adachi
Hideki Koyama
Shuki Mizutani
Tomohiro Morio
Publikationsdatum
01.03.2012
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 3/2012
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-012-1013-1

Weitere Artikel der Ausgabe 3/2012

International Journal of Hematology 3/2012 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.